Every 8-K that Quipt Home Medical Corp. (QIPT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow QIPT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full QIPT filings page.
Quipt Home Medical Corp. has been acquired and taken private. An affiliate of REM Aggregator, LLC, through 1567208 B.C. Ltd., bought all outstanding Quipt common shares for cash at US$3.65 per share under a court-approved plan of arrangement.
The transaction values the cash consideration for shares, options and RSUs at approximately $173 million. All options and restricted share units were cancelled in exchange for cash, subject to tax withholdings, with out-of-the-money options receiving no payment.
Quipt became an indirect wholly owned subsidiary of Parent, triggering a change of control. The company is delisting its shares from the Nasdaq Capital Market and Toronto Stock Exchange and plans to terminate its U.S. and Canadian reporting obligations. The board was reconstituted, with several directors and senior officers resigning and then some being reappointed under the new ownership structure.
Quipt Home Medical Corp. has received a final court order in British Columbia approving its previously announced plan of arrangement. Under this deal, affiliates of Kingswood Capital Management and Forager Capital Management will acquire all outstanding common shares for cash consideration of US$3.65 per share.
The transaction remains subject to customary closing conditions and is expected to close by March 16, 2026. After completion, Quipt’s shares are expected to be delisted from the Toronto Stock Exchange and the Nasdaq Capital Market, and the company is expected to cease being a reporting issuer in Canada and the United States.
Quipt Home Medical Corp. reported that its shareholders approved a special resolution for a plan of arrangement under British Columbia corporate law. Under this arrangement, affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC are to acquire all issued and outstanding common shares for cash consideration of US$3.65 per share.
At the special meeting, shareholders holding 29,672,136 shares, or about 66.93% of outstanding shares as of the record date, were represented. The arrangement resolution received support from 98.9% of votes cast overall and 98.7% of votes cast after excluding interested and related parties under MI 61-101. Quipt plans to seek a final court order on March 5, 2026, and completion of the transaction remains subject to court, stock exchange and regulatory approvals and other closing conditions.
Quipt Home Medical Corp. reports that the U.S. Hart-Scott-Rodino antitrust waiting period has expired for its planned acquisition, under which a purchaser will acquire all outstanding Quipt common shares for $3.65 per share in cash by way of a court-approved plan of arrangement in British Columbia. The expiration of the HSR waiting period removes a key U.S. antitrust condition but the transaction still depends on other customary closing conditions, including approval by Quipt shareholders. The company reminds investors that completion of the deal is uncertain and subject to risks, and directs securityholders to review the forthcoming definitive management information circular and proxy statement before voting.
Quipt Home Medical Corp. filed a report stating that on December 30, 2025 it issued a notice of meeting for a special meeting of shareholders scheduled for March 3, 2026. The notice, attached as Exhibit 99.1, relates to a proposed transaction involving Quipt, 1567208 B.C. LTD, and REM Aggregator, LLC.
The company highlights that expectations about the timing and completion of this proposed transaction are forward-looking statements and may change if regulatory, court, shareholder, or other approvals, or closing conditions, are delayed or not obtained. Quipt indicates it will file a detailed proxy statement and management information circular on Schedule 14A, which shareholders are urged to review in full when available before deciding how to vote on the proposed transaction.
Quipt Home Medical Corp. disclosed that it has released its financial results for the year ended September 30, 2025, in a press release dated December 15, 2025. This update relates to the company’s results of operations and financial condition and is being reported under a current report to regulators.
The press release is furnished as Exhibit 99.1 and includes financial information prepared under U.S. GAAP as well as Non-GAAP financial measures. It also provides reconciliations between these Non-GAAP measures and the most directly comparable GAAP figures, along with management’s explanation of why these alternative metrics are useful to investors. The information in this report and the exhibit is expressly treated as furnished, not filed, under U.S. securities laws.
Quipt Home Medical Corp. has entered into a definitive Arrangement Agreement to be acquired by entities affiliated with Kingswood Capital Management for US$3.65 in cash per common share via a court-approved plan of arrangement under British Columbia corporate law. The board unanimously approved the deal, judged the cash consideration fair from a financial point of view, and plans to recommend that shareholders vote in favor at a special meeting.
At closing, each common share (other than validly dissenting shares) will be exchanged for US$3.65 in cash, options will vest and be cashed out to the extent their exercise price is below that amount, and restricted share units will be settled for cash at US$3.65, all less applicable taxes. Following completion, Quipt’s shares are expected to be de-listed from the Nasdaq Capital Market and the Toronto Stock Exchange and de-registered in the United States, and the company will cease to be a Canadian reporting issuer.
The parties expect to close in the first half of 2026, subject to conditions including required shareholder approvals (such as a 66⅔% vote threshold), court approval, antitrust clearance under the Hart-Scott-Rodino Act, no Material Adverse Effect, and limits on dissent rights. Shareholders and certain insiders holding approximately 20.9% of the outstanding shares have signed voting support agreements in favor of the transaction, and Kingswood has provided an equity commitment to fund the cash consideration and related costs.
Quipt Home Medical Corp. reported that on August 27, 2025 it issued a press release confirming receipt of another unsolicited, non-binding and indicative proposal from Forager Capital Management, LLC. This indicates external interest in the company but does not represent a firm offer or agreement. The press release detailing the proposal is included as Exhibit 99.1 and incorporated by reference. The company is furnishing this information under Regulation FD, meaning it is sharing the same update with all investors at the same time.
Quipt Home Medical Corp. announced that on August 11, 2025 its subsidiary QHM Holdings entered an Equity Purchase Agreement to acquire a 60% membership interest in IRB Medical Equipment, LLC dba Hart Medical Equipment, a Michigan-based provider of durable medical equipment, point-of-service products, and related services. The seller will retain 40% and the company will operate as a joint venture under an amended operating agreement and an Administrative Support Services Agreement.
The purchase price equals 60% of a $35.0 million enterprise value with customary adjustments for cash (not less than $1.0 million), indebtedness, accrued payroll, certain Medicaid settlement amounts and working capital, producing an expected cash price of approximately $17.0–$18.0 million. Quipt expects to fund closing with existing cash and additional cash under its credit facility, subject to lender approval. If financing is not obtained and closing does not occur by September 30, 2025, Quipt may owe a $250,000 fee. The transaction is subject to customary closing conditions.
Quipt Home Medical Corp. announced a press release furnished on August 11, 2025 reporting its financial results for the quarter ended June 30, 2025. The filing states the press release is furnished as Exhibit 99.1 and that the information is furnished, not filed, under the Exchange Act.
The company discloses the press release includes Non-GAAP financial measures along with GAAP comparatives and reconciliations and explains management believes these measures provide useful supplemental information. The 8-K is signed by CFO Hardik Mehta and identifies Quipt as an emerging growth company incorporated in British Columbia, Canada.